Clinical Trials - Medical Device FDA's Program 2017

MessageThis Webinar is over
Date Aug 24, 2017
Time 10:00 AM
Cost 150.00
The topic is device clinical trials. This term refers to the use of medical

products on/in humans, in order to gain useful knowledge about the


Why should you Attend:
In spite of the long experience device companies have with clinical trials

regulations (published 25 years ago), many companies have found this area

an expensive trap. In fact, the only thing more expensive than a good

clinical trial is a bad clinical trial.

Areas Covered in the Session:
Valid Scientific Evidence
Phases of Device Human Studies
Significant/Non-Significant Risk
IDE Meaning, Content, Review
Exemption from IDE rules

Who Will Benefit:
R&D and Regulatory Staff
Management of R&D Regulatory

Speaker Profile:
Anna Longwell is currently principal attorney of the Palo Alto Law firm,

Longwell and Associates, which specializes in Food and Drug law. The firm

has expertise in US FDA expectations, regulation and law, affecting the

development and ultimate marketing of new medical products, drugs,

devices and biologics. They have served the regulatory needs of large (>$2

billion/year) divisions of Fortune 500 companies, and small (4 person)

biotech start-ups.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list